Life Science REIT announced the appointment of Richard Howell as an independent non-executive Director of the Company with effect from 3 May 2022. As part of a planned succession process, the Board anticipates that Richard will replace Dr. Sally Ann Forsyth OBE in the role of Chair of the Audit & Risk Committee (the "Committee") following his initial induction process and a subsequent RNS announcement will be made on his appointment as Chair of the Committee. In respect to the future rotation of Chair of the Committee, Sally Ann has been appointed as Sustainability Lead for the Company.